2043659-93-2
Chemical Structure
Cevidoplenib dimesylate
Synonym(s): SKI-O-703 dimesylate
- CAS No.: 2043659-93-2
- Formula:C27H35N7O9S2
- Molecular Weight:665.74
IUPAC Name: (S)-cyclopropyl(5-((4-(4-((4-hydroxyisoxazolidin-2-yl)methyl)-3-methyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-1-methyl-1H-indol-3-yl)methanone dimethanesulfonate
InChIKey: KGZICKLRNSIYNH-TXEPZDRESA-N
SMILES: O=C(C1CC1)C2=CN(C)C3=C2C=C(NC4=NC=CC(N5N=C(C)C(CN6OC[C@@H](O)C6)=C5)=N4)C=C3.CS(=O)(O)=O.CS(=O)(O)=O
Biological Activity: Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cevidoplenib dimesylate | 98.96% | Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cevidoplenib dimesylate (Standard) | ≥98% | Cevidoplenib dimesylate (Standard) is the analytical standard of Cevidoplenib (dimesylate) (HY-109082A). This product is intended for research and analytical applications. Cevidoplenib is an orally available inhibitor of spleen tyrosine Kinase (Syk), with potential anti-inflammatory and immunomodulating activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||